英菲格拉替尼哪儿能买,用法用量是怎样的?

Infigratinib is a small molecule ATP-competitive tyrosine kinase inhibitor of FGFR. It is the second cholangiocarcinoma-targeted drug, mainly targeting cholangiocarcinoma with FGFR2 fusion gene mutations. Blocks downstream signaling cascades by selectively binding and inhibiting FGFR activity, reducing cancer cell proliferation and inducing tumor cell death. So, where can I buy Infigratinib and what is the dosage?

Where can I buy Infigratinib?

Infigratinib is not currently on the market in China. Patients cannot buy this drug in domestic hospital pharmacies. They need to go abroad to purchase it. The journey is long and the risk is high. It is not suitable for patients to take the drug for a long time. Patients can also learn about Infigratinib, which is available overseas, through Medical Companion Travel. The price is affordable and it is guaranteed to be genuine, and the drug factory delivers it directly to their homes, which can reduce the financial burden on patients. It is not recommended for patients to use purchasing agents as they are easily deceived. For the specific cost of Infigratinib and the drug purchase process, it is recommended to consult the medical companion passenger service staff, and the drug purchase is guaranteed.

What is the dosage of Infigratinib?

Before taking infigratinib, it should be confirmed that the patient has FGFR2 gene fusion or rearrangement. If it does not exist, it should not be used. The recommended dose is 125mg, taken orally once a day, with 21 consecutive days of medication and 7 days of drug withdrawal, with a 28-day treatment cycle. Infigratinib should be taken on an empty stomach at least 1 hour before meals or 2 hours after meals. It needs to be taken at the same time every day and cannot be crushed, chewed or dissolved. Patients should not change the dosage and usage at will to avoid intolerance reactions.

Infigratinib will be launched in the United States on May 29, 2021. Infigratinib was originally developed by Novartis and introduced and developed by QED Therapeutics (BridgeBio Pharma). It is an oral, ATP-competitive, FGFR tyrosine kinase inhibitor. The above is where you can buy Infigratinib and what its usage and dosage are. I hope it can help you!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: